538 related articles for article (PubMed ID: 32741218)
21. Chilblain-like acral lesions during the COVID-19 pandemic ("COVID toes"): Histologic, immunofluorescence, and immunohistochemical study of 17 cases.
Kanitakis J; Lesort C; Danset M; Jullien D
J Am Acad Dermatol; 2020 Sep; 83(3):870-875. PubMed ID: 32502585
[TBL] [Abstract][Full Text] [Related]
22. Chilblains and COVID19 infection: Causality or coincidence? How to proceed?
Pistorius MA; Blaise S; Le Hello C; ; Barbarot S; Dréno B
J Med Vasc; 2020 Jul; 45(4):221-223. PubMed ID: 32571563
[No Abstract] [Full Text] [Related]
23. COVID-19: Diagnostic Testing and Challenges.
Ogbebor O; Min Z; Cheema T; Bhanot N
Crit Care Nurs Q; 2020; 43(4):343-348. PubMed ID: 32833771
[TBL] [Abstract][Full Text] [Related]
24. Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection.
Hughes M; Rogers S; Lepri G; Bruni C; Matucci-Cerinic M
Br J Dermatol; 2020 Sep; 183(3):596-598. PubMed ID: 32460349
[No Abstract] [Full Text] [Related]
25. SARS-CoV-2 diagnostic testing in Africa: needs and challenges.
Adebisi YA; Oke GI; Ademola PS; Chinemelum IG; Ogunkola IO; Lucero-Prisno Iii DE
Pan Afr Med J; 2020; 35(Suppl 2):4. PubMed ID: 32528615
[No Abstract] [Full Text] [Related]
26. High prevalence of cryofibrinogenemia in patients with chilblains during the COVID-19 outbreak.
Gómez-Fernández C; López-Sundh AE; González-Vela C; Ocejo-Vinyals JG; Mayor-Ibarguren A; Salas-Venero CA; Gutiérrez-Larrañaga M; Tejerina-Puente A; Fariñas MC; Cabero-Pérez MJ; López-Hoyos M; González-López MA
Int J Dermatol; 2020 Dec; 59(12):1475-1484. PubMed ID: 33070314
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic Stewardship: An Essential Element in a Rapidly Evolving COVID-19 Pandemic.
Shah AS; Tande AJ; Challener DW; O'Horo JC; Binnicker MJ; Berbari EF
Mayo Clin Proc; 2020 Sep; 95(9S):S17-S19. PubMed ID: 32807516
[No Abstract] [Full Text] [Related]
28. COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction-negative patient.
Santonja C; Heras F; Núñez L; Requena L
Br J Dermatol; 2020 Oct; 183(4):778-780. PubMed ID: 32585767
[No Abstract] [Full Text] [Related]
29. Chilblains in children in the time of COVID-19: New evidence with serology assay.
Colonna C; Spinelli F; Monzani NA; Ceriotti F; Gelmetti C
Pediatr Dermatol; 2020 Sep; 37(5):1000-1001. PubMed ID: 32533607
[No Abstract] [Full Text] [Related]
30. COVID toes and other cutaneous manifestations of COVID-19.
Rose-Sauld S; Dua A
J Wound Care; 2020 Sep; 29(9):486-487. PubMed ID: 32924822
[No Abstract] [Full Text] [Related]
31. A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.
Goetz L; Yang J; Greene W; Zhu Y
J Appl Lab Med; 2020 Nov; 5(6):1401-1405. PubMed ID: 32745181
[No Abstract] [Full Text] [Related]
32. SARS-CoV-2 infection in children in Parma.
Dodi I; Castellone E; Pappalardo M; Rubini M; Veronese P; Ruberto C; Bianchi L; Iovane B; Maffini V
Acta Biomed; 2020 May; 91(2):214-215. PubMed ID: 32420948
[TBL] [Abstract][Full Text] [Related]
33. When interferon tiptoes through COVID-19: Pernio-like lesions and their prognostic implications during SARS-CoV-2 infection.
Damsky W; Peterson D; King B
J Am Acad Dermatol; 2020 Sep; 83(3):e269-e270. PubMed ID: 32565206
[No Abstract] [Full Text] [Related]
34. Serological tests for COVID-19.
Bond K; Williams E; Howden BP; Williamson DA
Med J Aust; 2020 Nov; 213(9):397-399.e1. PubMed ID: 32892381
[No Abstract] [Full Text] [Related]
35. Gastrointestinal Presentation in COVID-19 in Indonesia: A Case Report.
Azwar MK; Kirana F; Kurniawan A; Handayani S; Setiati S
Acta Med Indones; 2020 Jan; 52(1):63-67. PubMed ID: 32291373
[TBL] [Abstract][Full Text] [Related]
36. [SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].
Erensoy S
Mikrobiyol Bul; 2020 Jul; 54(3):497-509. PubMed ID: 32755524
[TBL] [Abstract][Full Text] [Related]
37. Laboratory diagnosis for Covid-19: A mini-review.
Pizzol JLD; Hora VPD; Reis AJ; Vianna J; Ramis I; Groll AV; Silva PAD
Rev Soc Bras Med Trop; 2020; 53():e20200451. PubMed ID: 32876316
[TBL] [Abstract][Full Text] [Related]
38. The Brief Case: "Not Positive" or "Not Sure"-COVID-19-Negative Results in a Symptomatic Patient.
Parikh BA; Bailey TC; Lyons PG; Anderson NW
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703891
[No Abstract] [Full Text] [Related]
39. Treatment of COVID-19 induced chilblains with topical nitroglycerin.
Weingarten M; Abittan B; Rivera-Oyola R; Abittan AI; Weingarten M; Lebwohl M
Int J Dermatol; 2020 Dec; 59(12):1522-1524. PubMed ID: 33084032
[No Abstract] [Full Text] [Related]
40. A Comprehensive Review of Cutaneous Manifestations Associated with COVID-19.
Rahimi H; Tehranchinia Z
Biomed Res Int; 2020; 2020():1236520. PubMed ID: 32724793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
